PMS18 COST-EFFECTIVENESS OFABATACEPT IN PATIENTS WITH MODERATELYTO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN BRAZIL
May 1, 2008, 00:00
10.1016/S1098-3015(10)70820-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)70820-2/fulltext
Title :
PMS18 COST-EFFECTIVENESS OFABATACEPT IN PATIENTS WITH MODERATELYTO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70820-2&doi=10.1016/S1098-3015(10)70820-2
First page :
Section Title :
Open access? :
No
Section Order :
574